FORBEARANCE AGREEMENTForbearance Agreement • February 9th, 2018 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 9th, 2018 Company Industry JurisdictionThis FORBEARANCE AGREEMENT (this “Agreement”) is entered into as of February 5, 2018, by and among MEDITE Cancer Diagnostics, Inc., a Delaware corporation (“Borrower”), and GPB Debt Holdings II LLC, a Delaware limited liability company (“Lender”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Transaction Documents (as hereinafter defined).